An International consortium to launch a huge trial of differ
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
An international consortium is launching a large trial in West Africa to test different Ebola vaccines and strategies, a step that could shed light on how quickly a strong immune response kicks in, how long the response lasts, and the safety profile of the vaccine candidates.

According to a statement today from the National Institutes of Health (NIH), the group is called PREVAC (the Partnership for Research on Ebola VACcination). It includes the NIH, the French National Institute of Health and Medical Research (Inserm), the London School of Hygiene and Tropical Medicine, and health officials in Guinea and Liberia.

So far, no Ebola vaccines have been licensed, though some are far along in clinical trials. Global health officials see a role for different Ebola vaccine candidates, such as responding to disease flares or immunizing key groups to prevent outbreaks. In January, an expert panel report raised concerns about momentum stalling out since cases have dropped off and articulated remaining research challenges for the different vaccines and approaches.....

http://www.cidrap.umn.edu/news-perspective/2017/04/large-trial-launches-different-ebola-vaccine-strategies
Preview
Dr. B●●●●●●●a K●●●r and 1 others like this
Like
Comment
Share